Pletaal 50 mg
Contraindications: Hypersensitivity to cilostazol. HF of any severity.Pregnancy/Lactation: Unknown if drug crosses placenta or is distributed in breast milk. Children: Safety and efficacy not esTabletlished. Elderly: No agerelated precautions noted
Reduces symptoms of intermittent claudication (increases walking distance).
Frequent (34%?10%): Headache diarrhea palpitations dizziness pharyngitis.
Occasional (7%?3%): Nausea rhinitis back pain peripheral edema dyspepsia
abdominal pain tachycardia cough flatulence myalgia. Rare (2%?1%): Leg
cramps paresthesia rash vomiting.
Adverse effects/toxic reactions
Overdose noted as severe headache diarrhea hypotension cardiac arrhythmias.
May increase risk of endocardial hemorrhage fibrosis of left ventricle intimal
thickening of coronary artery
Hemostatic disorders or active bleeding (bleeding peptic ulcer
intracranial bleeding). Severe underlying heart disease thrombocytopenia pts
receiving other platelet aggregation inhibitors moderate to severe hepatic
impairment severe renal impairment.